Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines.

García-Morales P, Gómez-Martínez A, Carrato A, Martínez-Lacaci I, Barberá VM, Soto JL, Carrasco-García E, Menéndez-Gutierrez MP, Castro-Galache MD, Ferragut JA, Saceda M.

Mol Cancer Ther. 2005 Aug;4(8):1222-30.

2.

The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells.

Doi S, Soda H, Oka M, Tsurutani J, Kitazaki T, Nakamura Y, Fukuda M, Yamada Y, Kamihira S, Kohno S.

Mol Cancer Ther. 2004 Nov;3(11):1397-402.

3.
5.

Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA).

Henderson C, Mizzau M, Paroni G, Maestro R, Schneider C, Brancolini C.

J Biol Chem. 2003 Apr 4;278(14):12579-89. Epub 2003 Jan 29.

6.

Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization.

Arnoult D, Gaume B, Karbowski M, Sharpe JC, Cecconi F, Youle RJ.

EMBO J. 2003 Sep 1;22(17):4385-99.

7.

A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity.

Okada M, Adachi S, Imai T, Watanabe K, Toyokuni SY, Ueno M, Zervos AS, Kroemer G, Nakahata T.

Blood. 2004 Mar 15;103(6):2299-307. Epub 2003 Nov 26.

9.
10.

Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.

Klisovic DD, Katz SE, Effron D, Klisovic MI, Wickham J, Parthun MR, Guimond M, Marcucci G.

Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2390-8.

PMID:
12766035
11.
13.

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling.

Feng R, Ma H, Hassig CA, Payne JE, Smith ND, Mapara MY, Hager JH, Lentzsch S.

Mol Cancer Ther. 2008 Jun;7(6):1494-505. doi: 10.1158/1535-7163.MCT-08-0183.

14.

Histone deacetylase inhibitor trichostatin A induced caspase-independent apoptosis in human gastric cancer cell.

Wu ZQ, Zhang R, Chao C, Zhang JF, Zhang YQ.

Chin Med J (Engl). 2007 Dec 5;120(23):2112-8.

PMID:
18167185
16.

SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines.

Ryu JK, Lee WJ, Lee KH, Hwang JH, Kim YT, Yoon YB, Kim CY.

Cancer Lett. 2006 Jun 8;237(1):143-54. Epub 2005 Jul 11.

PMID:
16009488
17.

Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.

Kim SY, Park KW, Kim JY, Jeong IY, Byun MW, Park JE, Yee ST, Kim KH, Rhim JS, Yamada K, Seo KI.

Bioorg Med Chem Lett. 2008 Jan 1;18(1):199-204. Epub 2007 Oct 30.

PMID:
18024112
18.

Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.

Shankar S, Singh TR, Fandy TE, Luetrakul T, Ross DD, Srivastava RK.

Int J Mol Med. 2005 Dec;16(6):1125-38.

PMID:
16273296
20.

In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.

Brieger A, Boehrer S, Schaaf S, Nowak D, Ruthardt M, Kim SZ, Atadja P, Hoelzer D, Mitrou PS, Weidmann E, Chow KU.

Biochem Pharmacol. 2004 Jul 1;68(1):85-93.

PMID:
15183120

Supplemental Content

Support Center